PharmacoLearnIt’s Important to Know!

← Biopharmaceutics and Pharmacokinetics Practicals

Bioavailability of Common Drugs in an Animal or Human Model

bioavailability animal human model
bioavailability animal human model

1. Aim

To study year 4 biopharmaceutics 6 using supervised records and report the supported outcome. Actual case, sample, and result must be entered in the student record.

2. Requirements

Approved de-identified dataset or teaching case, current method, source identifiers, calibration and control records where relevant, graphing or calculation tool, supervisor, and privacy or safety procedure. Record the assigned sample and use approved software. Drug identity, dose, and acceptance criteria are to be recorded from the assigned current monograph or approved college method in the student record.

3. Theory

Bioavailability describes rate and extent of systemic exposure after a dose. The syllabus permits animal or human models but provides no drug or protocol. Prospective work requires ethical approval, consent where relevant, validated sampling, and bioanalysis. Students can first analyze de-identified approved concentration-time records.

4. Procedure

  1. Confirm the syllabus entry, approved source, ethics or privacy requirements, and method.
  2. Record actual labels, units, time points, controls, and missing information without guessing.
  3. Work through the supervised case or dataset: Confirm the authorized model and drug, then review dose, sampling times, concentration assay, and ethics documentation. Estimate AUC and peak measures from valid data only.
  4. Separate raw observations from calculations and check method suitability.
  5. Use verified formulae and local software only if the full dataset and method support them.
  6. State the supported result, limitations, and every missing item as Record here.

5. Observation and calculation

Student record field Entry
Case or product Record here
Method Record here
Observation Record here
Inference Record here
Supervisor check Record here
Outcome Record here

Assumed values or observations for practice only: Assumed concentration-time data have an assumed peak of 5 mg/L. This invented value is not a dose recommendation or actual exposure. All invented inputs and outputs are assumed, not a patient result or laboratory instruction.

6. Output or final result

Provide a labelled concentration-time profile and supervisor-reviewed conclusion. Record the supervised outcome here.

Teaching-lab safety: Clinical cases must be de-identified and supervised. Human or animal bioavailability work requires prior ethical authorization. No assumed example authorizes dosing or sampling. Software-dependent fitting belongs in the actual lab with its approved program.

This page is a supervised-activity guide; it does not report a completed case.

7. Sources

← Extent of Plasma Protein Binding at Different ConcentrationsCalculate Ka, Ke, Half-Life, Cmax, AUC, AUMC and MRT →

Back to Biopharmaceutics and Pharmacokinetics Practicals · All Pharm D Practicals · Pharm D

Theory notes: Pharm D Year 4, 4.5 Biopharmaceutics and Pharmacokinetics